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BACKGROUND. Previous studies identified disparities in incidence rates of cancers
of the oral cavity and pharynx between American Indians/Alaska Natives (AI/AN)
and non-Hispanic whites (NHW) and differences between various AI/AN popula-
tions. Reporting among AI/AN has been hampered by: 1) heterogeneity among
various anatomic sites of oral cavity and pharyngeal cancers obscuring unique
patterns of individual anatomic sites; 2) race misclassification and underreporting
of AI/AN; and 3) sparseness of data needed to identify regional variations.
METHODS. To improve race classification of AI/AN, data from US central cancer
registries were linked with Indian Health Service (IHS) records. AI/AN incidence
data from 1999 to 2004 were stratified by sex, age, stage at diagnosis, and ana-
tomic subsite for 6 IHS geographic regions and compared with NHW popula-
tions.
RESULTS. For all oral cavity and pharynx cancers combined, among residents of
Contract Health Service Delivery Area counties, AI/AN overall had significantly
lower incidence rates than NHW (8.5 vs 11.0). However, AI/AN rates were signifi-
cantly higher in the Northern Plains (13.9 vs 10.5) and Alaska (16.3 vs 10.6), signifi-
cantly lower in the Pacific Coast (7.7 vs 11.6) and Southwest (3.3 vs 10.4), and
similar in the Southern Plains (11.4). Overall AI/AN males had higher incidence
rates than AI/AN women. Nasopharyngeal cancer was more frequent (1.1 AI/AN
vs 0.4 NHW), and tongue cancer less frequent (1.6 AI/AN vs 2.9 NHW) in AI/AN
than NHW populations; however, rates varied by region. Stage distribution was
modestly less favorable for AI/AN compared with NHW populations.
CONCLUSIONS. Variation by region, anatomic site, and sex indicates a need for
research into etiologic factors and attention to regional risk factor profiles when
planning cancer control programs. Cancer 2008;113(5 suppl):1256–65. Published
2008 by the American Cancer Society.*
KEYWORDS: cancer, incidence, oral cavity, pharynx, American Indian/Alaska
Native, NPCR, SEER.
C ancers of the oral cavity and pharynx include malignancies ofthe lip, tongue, floor of mouth, gum and other mouth, salivary
gland, oropharynx, tonsil, nasopharynx, hypopharynx, and ‘‘other
oral cavity and pharynx.’’ Previous studies have identified important
disparities in cancers of the oral cavity and pharynx among Ameri-
can Indian/Alaskan Native (AI/AN) populations, and between AI/AN
and other populations, including non-Hispanic whites (NHW).1-3
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Higher incidence rates have been found for some AI/
AN than NHW populations in the same geographic
areas and for males as compared with females. How-
ever, previous studies have been hampered by lack of
data in individual anatomic cancer sites, misclassifi-
cation of AI/AN individuals, and small numbers of
cases.
The purpose of this study is to improve the char-
acterization of incidence of cancers of the oral cavity
and pharynx in the AI/AN population, relative to the
NHW population, by using techniques to minimize
the effect of race misclassification in cancer surveil-
lance data. This study further examines incidence
rates of individual anatomic cancer sites in the oral
cancer and pharynx group and stratifies findings by
Indian Health Service (IHS) region.
MATERIALS AND METHODS
Detailed descriptions of the data sources and meth-
ods used for this analysis are found in another paper
in this supplement.4
Cancer Cases
Population-based central cancer registries collect in-
formation on all new cancer cases within their
geographic boundaries. They participate in the Sur-
veillance, Epidemiology, and End Results (SEER) pro-
gram of the National Cancer Institute (NCI), the
National Program for Cancer Registries (NPCR) of
the Centers for Disease Control and Prevention
(CDC), or both.1,5 Primary cancer site and histology
data are coded according to the International Classi-
fication of Diseases for Oncology (ICD-O) edition in
use at the time of diagnosis and converted to the
Third Edition.6 Ten anatomic sites of cancers of the
oral cavity and pharynx were defined with the follow-
ing ICD-O codes: lip (C00.0-C00.9), tongue (C01.9-
C02.9), gum and other mouth (C03.0-C03.9, C05.0-
C06.9), floor of the mouth (C04.0-C04.9), salivary
gland (C07.9-C08.9), oropharynx (C10.0-C10.9), tonsil
(C09.0-C09.9), nasopharynx (C11.0-C11.9), hypophar-
ynx (C12.9-C13.9), and other (C14.0, C14.2-C14.8).
Kaposi sarcomas at these sites were excluded, as
were histology codes 9590 to 9989, 9050 to 9055, and
9140. All cases of oral cavity and pharynx cancers
included in this study were ascertained by popula-
tion-based cancer registries that agreed to participate
and met the United States Cancer Statistics standards
for high-quality data within states5; the states that
met quality criteria are listed in the footnotes of
Table 1.
Coding race for AI/AN cancer cases combines in-
formation from data linkages with the IHS patient
registration database and the multiple race fields in
central cancer registry records.7 The IHS provides
medical services to AI/AN persons who are members
of federally recognized tribes. To reduce the misclas-
sification of AI/AN race, central cancer registries
worked with the IHS to link all case records with the
IHS patient registration database to identify AI/AN
cases misclassified as non-Native. Linkages were
conducted using LinkPlus, a probabilistic linkage
software program developed by CDC.8 The informa-
tion from the linkages was then combined with the
multiple race fields coded in cancer registry records.
Further details about linkages and coding rules for
multiple races are described elsewhere in this Sup-
plement.4 To further improve race classification,
analyses focused on Contract Health Service Delivery
Area (CHSDA) counties (Fig. 1), which generally con-
tain federally recognized tribal lands or are adjacent
to tribal lands. The proportions of AI/AN in relation
to total population are higher in CHSDA counties
than in non-CHSDA counties, and previous analyses
indicate less race misclassification for AI/AN in these
counties.9 About 56% of the US AI/AN population re-
side in CHSDA counties. This proportion varies by
IHS region: Alaska 5 100%; East 5 13.1%; Northern
Plains 5 59.0%; Southern Plains 5 64.1%; Pacific
Coast 5 55.6%; Southwest 5 87.5%. In addition, inci-
dence rates were stratified by IHS regions (Alaska,
Pacific Coast, Northern Plains, Southern Plains,
Southwest, and East) to evaluate the geographic vari-
ation of cancer incidence in the AI/AN population
(Fig. 1). Additional details about CHSDA counties
and IHS are provided elsewhere.4
Cancer stage data for this report spanned
changes in SEER summary stage coding. Stage was
coded according to SEER Summary Stage 1977 rules
for diagnosis years 1999 to 2000 and to SEER Sum-
mary Stage 2000 rules for 2001 to 2003. The numbers
of cases and percent of cases at the local, regional,
and distant stages were examined for all instances of
differences between SEER Summary Stage 1977 and
2000 for oral cavity and pharynx cancers. Because
changes were observed to be minimal, stage data
were combined for 1999 to 2003.10,11 Collaborative
staging was introduced by both NPCR and SEER Pro-
grams in 2004. Although SEER summary stage is
available through collaborative staging, evaluation of
this data for consistency with previously coded data
has not been completed, so stage at diagnosis data
from 2004 were not included in these analyses.
Population Estimates
In the 2000 census, the US Census Bureau for the
first time allowed respondents to identify themselves
Oral Cavity and Pharynx Cancer in AI/AN/Reichman et al 1257
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in 1 or more race fields.7 To facilitate comparison
with population estimates based on a single race
field before 2000, the CDC’s National Center for
Health Statistics, in collaboration with the Census
Bureau, developed a technique of bridging race cate-
gories into single-race annual population estimates.12
The NCI makes further refinements to these esti-
mates regarding race and county geographic codes;
these estimates were used as denominators in this
report.13
Statistical Analyses
Cancer incidence rates are expressed per 100,000
persons and are age-adjusted by 19 age groups to the
2000 US standard population. Rates and 95% modi-
fied gamma confidence intervals (CI) are generated
using SEER*Stat Software.14,15 Percent distributions
(stage of disease at diagnosis and data on individual
anatomic sites) are also age-adjusted. For presenta-
tion, counts are suppressed when the category con-
tains 5 or fewer cases. Groupings for age-specific
analyses were selected based on the distribution for
all oral cavity and pharyngeal cancer cases com-
bined. Rate ratios (RRs)—the age-adjusted incidence
rate among AI/AN divided by the age-adjusted inci-
dence rate among NHW—and 95% CI were calcu-
lated to facilitate regional comparisons of incidence
rates between AI/AN and NHW populations.
RESULTS
AI/AN incidence rates for all cancers of the oral cav-
ity and pharynx combined showed substantial re-
gional variation compared with NHW (Table 1).
Furthermore incidence rates for all US counties in
the dataset were generally lower than those in
CHSDA counties where race misclassification is
lower. Therefore, subsequent results and discussion
are limited to CHSDA counties unless otherwise
noted. Over all regions, NHW had a higher incidence
rate for cancers of the oral cavity and pharynx (11.0)
than did AI/AN (8.5). Among AI/AN, incidence rates
for both sexes and all oral cavity and pharynx can-
cers combined ranged from 3.3 in the Southwest to
16.3 in Alaska. Rates did not vary substantially in the
IHS regions among the NHW population. Incidence
rates were generally higher for males than females
among both AI/AN (male:female rate ratio [RR] 2.7)
and NHW (male:female RR, 2.6) for all areas com-
bined. However, there is much more geographic vari-
ation in the male:female RR for for AI/AN (from 1.7
in Alaska to 3.2 in the Pacific Coast) than for NHW
(range 2.5 to 3.1).
The incidence RRs for AI/AN to NHW varied
across IHS regions, with AI/AN having significantly
higher incidence rates in the Northern Plains and
Alaska for both sexes combined, for males in the
Northern Plains, and for females in Alaska. In the
FIGURE 1. States and Contract Health Service Delivery Areas (CHSDA) counties by Indian Health Service Region are depicted.
Oral Cavity and Pharynx Cancer in AI/AN/Reichman et al 1259
TABLE 2
Oral Cavity and Pharyngeal Cancer Incidence Rates and Percentage Distribution by Anatomic Site and Indian Health Service Region for
American Indians/Alaska Nativesa and Non-Hispanic Whites, CHSDA Counties, United States, 1999 to 2004
AI/AN NHW AI/AN:NHW
Region Anatomic Site Count Ratea 95% CI % of Casesb Count Ratea 95% CI % of Casesb Rate Ratiod
Northern Plains Lip 7 0.9 0.3-1.9 6.5 687 1.3 1.2-1.4 12.4 0.68
Tongue 19 2.5 1.5-4.0 18.0 1,294 2.6 2.4-2.7 24.8 0.98
Gum and other mouth 14 2.1 1.1-3.7 15.1 784 1.5 1.4-1.6 14.3 1.40
Floor of mouth 11 1.2 0.6-2.2 8.6 394 0.8 0.7-0.9 7.6 1.55
Salivary gland 11 1.4 0.6-2.6 10.1 619 1.2 1.1-1.3 11.4 1.13
Oropharynx  0.5 0.1-1.2 3.6 205 0.4 0.4-0.5 3.8 1.14
Tonsil 21 2.3 1.4-3.6 16.5 663 1.3 1.2-1.4 12.4 1.74d
Nasopharynx 6 0.7 0.2-1.5 5.0 173 0.3 0.3-0.4 2.9 1.95
Hypopharynx 10 1.5 0.7-2.8 10.8 378 0.7 0.7-0.8 6.7 2.04
Other oral cavity & pharynx  0.8 0.2-1.8 5.8 127 0.2 0.2-0.3 1.9 3.15
All oral cavity & pharynx cancers 108 13.9 11.2-17.0 100.0 5,324 10.5 10.2-10.8 100.0 1.32d
Alaskac Lip  1.2 0.3-3.0 7.4 14 0.9 0.5-1.6 8.5 1.32
Tongue 12 2.8 1.4-5.0 17.2 64 2.9 2.2-3.8 27.4 0.97
Gum and other mouth  1.3 0.4-3.1 8.0 22 1.2 0.7-1.8 11.3 1.14
Floor of mouth 7 1.8 0.7-3.7 11.0 12 0.6 0.3-1.0 5.7 3.12d
Salivary gland  1.1 0.3-2.5 6.7 22 1.1 0.7-1.8 10.4 0.95
Oropharynx  0.2 0.0-1.2 1.2 12 0.6 0.3-1.1 5.7 0.35
Tonsil  0.6 0.1-1.8 3.7 37 1.5 1.0-2.1 14.2 0.38
Nasopharynx 27 6.8 4.4-10.0 41.7 17 0.8 0.4-1.3 7.5 8.82d
Hypopharynx  0.4 0.1-1.6 2.5 15 0.8 0.4-1.3 7.5 0.55
Other oral cavity & pharynx   NA NA 6 0.3 0.1-0.6 NA 
All oral cavity & pharynx cancers 66 16.3 12.4-20.8 100.0 221 10.6 9.1-12.3 100.0 1.53d
Southern Plains Lip 19 1.5 0.9-2.4 13.2 394 2.0 1.8-2.2 17.1 0.77
Tongue 26 1.9 1.2-2.8 16.7 512 2.6 2.4-2.9 22.2 0.72
Gum and other mouth 24 1.8 1.1-2.6 15.8 313 1.6 1.4-1.8 13.7 1.13
Floor of mouth 9 0.6 0.3-1.2 5.3 124 0.6 0.5-0.7 5.1 1.00
Salivary gland 12 0.8 0.4-1.4 7.0 260 1.3 1.2-1.5 11.1 0.59
Oropharynx  0.2 0.1-0.6 1.8 86 0.4 0.3-0.5 3.4 0.57
Tonsil 32 2.0 1.4-2.9 17.5 320 1.7 1.5-1.9 14.5 1.21
Nasopharynx 15 0.9 0.5-1.6 7.9 86 0.5 0.4-0.6 4.3 2.03d
Hypopharynx 14 1.1 0.6-1.8 9.6 128 0.6 0.5-0.8 5.1 1.71
Other oral cavity & pharynx 7 0.5 0.2-1.1 4.4 69 0.3 0.3-0.4 2.6 1.55
All oral cavity & pharynx cancers 162 11.4 9.7-13.4 100.0 2,292 11.7 11.2-12.2 100.0 0.98
Pacific Coast Lip 8 0.7 0.3-1.3 9.1 1,183 1.3 1.2-1.3 11.2 0.52
Tongue 31 2.0 1.3-3.0 26.0 2,951 3.2 3.0-3.3 27.6 0.65d
Gum and other mouth 14 0.9 0.5-1.5 11.7 1,544 1.6 1.6-1.7 13.8 0.55d
Floor of mouth  0.3 0.1-0.7 3.9 732 0.8 0.7-0.8 6.9 0.33
Salivary gland 8 0.5 0.2-0.9 6.5 1,110 1.2 1.1-1.3 10.3 0.38d
Oropharynx  0.1 0.0-0.4 1.3 319 0.3 0.3-0.4 2.6 0.29
Tonsil 24 1.6 1.0-2.4 20.8 1,662 1.8 1.7-1.9 15.5 0.89
Nasopharynx 14 0.8 0.4-1.4 10.4 353 0.4 0.3-0.4 3.4 2.14d
Hypopharynx 10 0.7 0.3-1.4 9.1 721 0.8 0.7-0.8 6.9 0.97
Other oral cavity & pharynx  0.1 0.0-0.5 1.3 286 0.3 0.3-0.3 2.6 0.48
All oral cavity & pharynx cancers 118 7.7 6.3-9.3 100.0 10,861 11.6 11.4-11.8 100.0 0.66d
East Lip   NA NA 438 0.7 0.6-0.7 NA 
Tongue 6 1.6 0.6-3.5 21.3 1,900 3.0 2.8-3.1 27.3 0.54
Gum and other mouth  1.8 0.5-4.0 24.0 1,130 1.7 1.6-1.8 15.5 1.03
Floor of mouth   NA NA 514 0.8 0.7-0.9 NA 
Salivary gland  1.2 0.3-2.9 16.0 848 1.3 1.2-1.4 11.8 0.89
Oropharynx  0.2 0.0-1.3 2.7 317 0.5 0.4-0.5 4.5 0.43
Tonsil 8 1.8 0.8-3.7 24.0 962 1.5 1.4-1.6 13.6 1.19
Nasopharynx  0.2 0.0-1.4 2.7 273 0.4 0.4-0.5 3.6 0.57
Hypopharynx  0.2 0.0-1.4 2.7 520 0.8 0.7-0.9 7.3 0.29
Other oral cavity & pharynx  0.5 0.0-2.1 6.7 233 0.4 0.3-0.4 3.6 1.35
All oral cavity & pharynx cancers 27 7.5 4.8-11.0 100.0 7,135 11.0 10.7-11.2 100.0 0.68
(continued)
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Southern Plains AI/AN and NHW incidence rates are
comparable. For other regions and for all regions
combined AI/AN incidence rates are lower than
NHW rates, reaching significance in each region, for
males, females, and both sexes combined except in
the East.
Incidence rates, counts, percent distributions,
and RRs for individual anatomic sites of oral cavity
and pharynx cancers in the 6 IHS regions and for all
regions combined for CHSDA counties are shown in
Table 2. For all regions combined, AI/AN have a sig-
nificantly lower incidence rate of cancer of the ton-
gue (1.6) than NHW (2.9), whereas AI/AN have a
significantly higher rate of nasopharyngeal cancer
(1.1) than NHW (0.4). Rates for other anatomic sites
are generally modestly lower in AI/AN populations
for all regions combined, reaching significance for
cancer of the lip, gum and other mouth, floor of
mouth, salivary gland, and oropharynx. When ana-
lyzed by region, significantly higher AI/AN incidence
rates of nasopharyngeal cancer compared with NHW
are noted in Alaska (RR, 8.82), the Southern Plains
(RR, 2.03), and the Pacific Coast (RR, 2.14). AI/AN
incidence rates are significantly higher than NHW
rates for tonsillar cancer in the Northern Plains (RR,
1.74) and for cancer of the floor of the mouth in
Alaska (RR, 3.12). The incidence rate for cancer of
the tongue is similar among AI/AN and NHW in
Alaska and the Northern Plains and generally lower
for AI/AN than NHW elsewhere, with significance
reached in the Southwest and Pacific Coast. Other
oral cavity and pharynx cancers are generally diag-
nosed less frequently among AI/AN than NHW.
The age at diagnosis for oral cavity and pharynx
cancers is lower for AI/AN than for NHW, with 36.3%
of cases in AI/AN diagnosed at age 65 years or older
as compared with 48.8% of cases among NHW (Table
3). This pattern holds true for all regions of the coun-
try except for Alaska, where the percentage of cases
diagnosed at age 65 years or older is 39.4% for AI/AN
and 35.7% for NHW. In general, the pattern of
younger age at diagnosis among AI/AN than NHW
TABLE 2
(continued)
AI/AN NHW AI/AN:NHW
Region Anatomic Site Count Ratea 95% CI % of Casesb Count Ratea 95% CI % of Casesb Rate Ratiod
Southwest Lip  0.2 0.1-0.5 6.1 413 1.0 0.9-1.1 9.6 0.22
Tongue 7 0.4 0.1-0.7 12.1 1,238 2.9 2.8-3.1 27.9 0.12d
Gum and other mouth 8 0.4 0.2-0.8 12.1 578 1.3 1.2-1.5 12.5 0.32d
Floor of mouth  0.2 0.0-0.5 6.1 340 0.8 0.7-0.9 7.7 0.24
Salivary gland 22 1.0 0.6-1.6 30.3 500 1.2 1.1-1.3 11.5 0.88
Oropharynx   NA NA 150 0.3 0.3-0.4 NA 
Tonsil  0.2 0.1-0.5 6.1 589 1.4 1.3-1.5 13.5 0.15
Nasopharynx 11 0.5 0.2-0.9 15.2 162 0.4 0.3-0.5 3.8 1.19
Hypopharynx  0.3 0.1-0.7 9.1 292 0.7 0.6-0.7 6.7 0.43
Other oral cavity & pharynx  0.1 0.0-0.3 3.0 150 0.3 0.3-0.4 2.9 0.19
All oral cavity & pharynx cancers 67 3.3 2.5-4.2 100.0 4,412 10.4 10.1-10.7 100.0 0.32d
Total Lip 43 0.8 0.5-1.0 9.4 3,129 1.1 1.1-1.2 10.0 0.67d
Tongue 101 1.6 1.3-2.0 18.8 7,959 2.9 2.9-3.0 26.4 0.55d
Gum and other mouth 70 1.2 0.9-1.5 14.1 4,371 1.6 1.5-1.6 14.5 0.76d
Floor of mouth 34 0.5 0.4-0.8 5.9 2,116 0.8 0.7-0.8 7.3 0.70d
Salivary gland 62 0.9 0.7-1.2 10.6 3,359 1.2 1.2-1.3 10.9 0.73d
Oropharynx 12 0.2 0.1-0.3 2.4 1,089 0.4 0.4-0.4 3.6 0.41d
Tonsil 93 1.3 1.0-1.6 15.3 4,233 1.6 1.5-1.6 14.5 0.82
Nasopharynx 74 1.1 0.8-1.4 12.9 1,064 0.4 0.4-0.4 3.6 2.68d
Hypopharynx 42 0.7 0.5-1.0 8.2 2,054 0.7 0.7-0.8 6.4 0.99
Other oral cavity & pharynx 17 0.3 0.2-0.5 3.5 871 0.3 0.3-0.3 2.7 0.96
All oral cavity & pharynx cancers 548 8.5 7.8-9.3 100.0 30,245 11.0 10.9-11.2 100.0 0.77d
Source: the National Program of Cancer Registries of the Centers for Disease Control and Prevention and/or the Surveillance, Epidemiology, and End Results program of the National Cancer Institute; see Table
1 for states included.
CHSDA indicates Contract Health Service Delivery Areas; NHW, non-Hispanic whites; AI/AN, American Indians/Alaska Natives; CI, confidence interval; NA, not available.
a Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups, Census P25-1130).
b Percentage anatomic site distribution is age-adjusted to the 2000 U.S. standard population and may not add to 100.0% due to rounding.
c Rates and rate ratios for Alaska in the CHSDA counties section is the same as those in the All Counties section because all counties in Alaska are CHSDA counties.
d Rate ratio is statistically significant (P < .05).
 Counts less than 6 are suppressed; if no cases were reported, then row percentages, rates, and rate ratios could not be calculated.
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holds true when cancers at individual anatomic sites
(except nasopharyngeal cancer) are examined (data
not shown). Exceptions occur for tongue cancer in
the Northern Plains, the Southern Plains, and Alaska
and for hypopharynx cancer in the Northern Plains.
For those residing in CHSDA counties, stage at
diagnosis was examined for all cancers of the oral
cavity and pharynx combined (Table 4). Comparing
AI/AN stage distribution to that for NHW for all
regions combined, the percentage of cancers diag-
nosed at the local stage is modestly higher for NHW,
similar for the regional stage, and modestly lower for
NHW at the distant stage. For Alaska, 28.6% of can-
cers are diagnosed at the distant stage for AI/AN as
compared with 7.5% for NHW. Similarly, in the
Southwest, distant stage diagnoses comprise 18.8%
of cancer cases for AI/AN but only 8.6% for NHW.
Diagnoses at the localized stage are notably lower for
AI/AN than for NHW in Alaska (24.6% vs 35.8%) and
the Northern Plains (30.7% vs 42.1%). When stage is
examined by individual anatomic sites, similar pat-
terns are observed (data not shown). However, for
cancer of the tonsil, a greater percentage of cases
among AI/AN are diagnosed at the local stage
(24.7%) than among NHW (15.5%). Salivary gland
cancer is similarly diagnosed more frequently at ear-
lier stages in AI/AN (64.7%) than in NHW (44.6%).
DISCUSSION
The incidence rate for all cancers of the oral cavity
and pharynx combined among AI/AN in CHSDA
counties in the US is lower than among NHW (8.5 vs
11.0). However, detailed analyses by individual ana-
tomic cancer sites and/or by IHS geographic regions
show a much more varied picture. In particular, can-
cers of the tongue make up a smaller, whereas naso-
pharyngeal cancers make up a much larger,
proportion of these cancers in AI/AN than NHW. In
Alaska, the incidence rates for all cancers of the oral
cavity and pharynx is significantly higher for AI/AN
than for NHW (RR, 1.53). In addition, nasopharyn-
geal cancer stands out as having significantly higher
incidence rates among AI/AN than NHW in Alaska,
the Southern Plains, and the Pacific Coast. Nasopha-
ryngeal cancers comprise 42% of all Alaskan AI/AN
cancers of the oral cavity and pharynx. Other
instances of significantly higher incidence rates
TABLE 3
Oral Cavity and Pharyngeal Cancer Incidence Rates and Percentage Distribution by Age and Indian Health Service Region for
American Indians/Alaska Natives and Non-Hispanic Whites, CHSDA Counties, United States, 1999 to 2004
<50 Years 50-64 Years 651 Years Total
IHS Region Count Row %a Rateb 95% CI Count Row %a Rateb 95% CI Count Row %a Rateb 95% CI Count Row %a Rateb 95% CI
American Indian/Alaska Native
Northern Plains 21 19.4 2.3 1.4-3.5 42 38.9 27.9 20.1-37.7 45 41.7 63.7c 45.8-86.3 108 100 13.9c 11.2-17.0
Alaska 12 18.2 2.8 1.5-4.9 28 42.4 39.4c 26.1-57.0 26 39.4 65.7 42.4-97.7 66 100 16.3c 12.4-20.8
Southern Plains 42 25.9 3.3 2.4-4.5 61 37.7 25.3 19.4-32.5 59 36.4 41.3 31.4-53.4 162 100 11.4 9.7-13.4
Pacific Coast 33 28.0 2.1 1.5-3.0 50 42.4 18.4d 13.7-24.3 35 29.7 26.8d 18.4-37.8 118 100 7.7d 6.3-9.3
East 6 22.2 1.7 0.6-3.7 12 44.4 19.0 9.8-33.1 9 33.3 26.8 12.1-51.8 27 100 7.5 4.8-11.0
Southwest 21 31.3 1.0d 0.6-1.5 21 31.3 6.3d 3.9-9.7 25 37.3 12.7d 8.1-19.0 67 100 3.3d 2.5-4.2
Total 135 24.6 2.1d 1.7-2.4 214 39.1 19.0d 16.5-21.7 199 36.3 33.1d 28.6-38.1 548 1000 8.5d 7.8-9.3
Non-Hispanic white
Northern Plains 877 16.5 2.6 2.4-2.8 1,857 34.9 24.2 23.1-25.3 2,590 48.6 39.5 38.0-41.0 5,324 100 10.5 10.2-10.8
Alaska 53 24.0 2.3 1.7-3.0 89 40.3 20.5 16.4-25.2 79 35.7 46.9 36.9-58.7 221 100 10.6 9.1-12.3
Southern Plains 364 15.9 3.0 2.7-3.4 749 32.7 25.0 23.3-26.9 1,179 51.4 45.2 42.7-47.9 2,292 100 11.7 11.2-12.2
Pacific Coast 1,652 15.2 2.7 2.5-2.8 3,861 35.5 26.6 25.8-27.5 5,348 49.2 44.9 43.7-46.2 10,861 100 11.6 11.4-11.8
East 1,101 15.4 2.8 2.6-3.0 2,532 35.5 26.5 25.5-27.5 3,502 49.1 39.4 38.1-40.8 7,135 100 11.0 10.7-11.2
Southwest 616 14.0 2.5 2.3-2.7 1,732 39.3 26.5 25.3-27.8 2,064 46.8 36.3 34.8-37.9 4,412 100 10.4 10.1-10.7
Total 4,663 15.4 2.7 2.6-2.8 10,820 35.8 25.9 25.4-26.4 14,762 48.8 41.2 40.6-41.9 30,245 100 11.0 10.9-11.2
Source: the National Program of Cancer Registries of the Centers for Disease Control and Prevention and/or the Surveillance, Epidemiology, and End Results program of the National Cancer Institute; see Table
1 for states included.
CHSDA indicates Contract Health Service Delivery Areas; IHS, Indian Health Service; CI: confidence interval.
a Percentages may not add up to 100.0% due to rounding.
b Rates are per 100,000 persons and are age-adjusted to the 2000 US standard population (19 age groups, Census P25-1130).
c The American Indian/Alaska Native (AI/AN) rate is statistically significantly higher than the non-Hispanic white (NHW) rate (P < .05).
d AI/AN rate is statistically significantly lower than the NHW rate (P < .05).
 Counts less than 6 are suppressed; if no cases were reported, then row percentages and rates could not be calculated.
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among AI/AN than NHW in the same geographic
region are indicated above. It is important to take
differences revealed in the detailed analyses into
account when describing the burden of cancer and
in cancer control planning. The age at diagnosis for
all cancers of the oral cavity and pharynx was found
to be lower for AI/AN than for NHW.
Tobacco use is by far the greatest risk factor for
oral cavity and pharynx cancers.16-18 AI/AN are more
likely to be current smokers (31.1%) than NHW
(22.8%), as reported by the Behavioral Risk Factor Sur-
veillance Surveys (BRFSS) for years 2000 to 2006.19
High rates of oral cavity and pharynx cancers among
AI/AN correspond with high smoking prevalence esti-
mates with 1 exception. Smoking prevalence in the
East (36.5%) is high; however, the overall rate of oral
cavity and pharynx cancer is among the lowest (7.5
per 100,000). However, the East (Fig. 1) has a low per-
centage of CHSDA counties, which may affect exter-
nal validity of cancer incidence data. In the
Southwest, where the prevalence of current smoking
is low (21.1%),19 cancer rates for oral cavity and phar-
ynx are also low (3.3 per 100,000). Oral cavity and
pharynx cancers are up to 5 times more common in
drinkers than nondrinkers.17,20 Alcohol strongly
increases a smoker’s risk of cancer of the oral cavity
and pharynx, possibly by increasing the exposure to
carcinogens.21-23 BRFSS 2000 to 200619 data indicate a
similar pattern across IHS regions of self-reported
heavy drinking among AI/AN groups (range, 3%-7%)
and NHW (6%).
Other major risk factors for oral cavity and phar-
ynx cancers include a diet low in fruits and vegeta-
bles and, for some anatomic sites, viral infection.17,24
AI/AN and NHW persons reported to BRFSS a similar
prevalence of consuming 5 or more servings of fruits
and vegetables per day with little variation by IHS
region.19 Risk factors also vary for individual anatomic
sites. Exposures to sunlight, outdoor occupation, and
rural residence have been identified as risk factors for
lip cancer. Human papilloma virus has been asso-
ciated with cancers of the tonsil, base of the tongue,
and oropharynx.25,26 The incidence patterns of oral
cavity and pharyngeal cancers observed in the present
study may reflect racial/ethnic and regional differ-
ences in exposure to these and other factors.
Epstein-Barr virus (EBV) is almost always found
in nasopharyngeal cancer cells.27 Infection with EBV
alone is not sufficient to cause nasopharyngeal can-
cer. In studies primarily of Asian populations, naso-
pharyngeal cancer has been found to be associated
with consumption of a variety of preserved foods be-
ginning at an early age.28 Occupation exposures to
formaldehyde, wood dust, and wood preservatives
may increase risk for nasopharyngeal cancer.29,30
This study shows that Alaska Native people have
uniquely increased risk compared with other AI/AN
populations in the United States. EBV has been con-
firmed present in nasopharyngeal cancer tissues
among Alaska Natives,31 but the role of genetic,
environmental, and diet factors in AI/AN persons in
Alaska has not been identified.
The presentation of incidence rates for individual
anatomic sites for cancers of the oral cavity and
pharynx for the 6 IHS regions is possible because of
the matching of NPCR and SEER data with the IHS
health database, thereby enhancing classification of
AI/AN individuals. Limitations of this linkage include
exclusion of AI/AN cases from areas with little or no
provision of IHS medical services, including many
urban areas. Also, some individuals who are AI/AN
may access healthcare from other sources. In gen-
eral, AI/AN are much more accurately classified in
CHSDA counties than in non-CHSDA counties. For
this reason, CHSDA counties form the basis of most
analyses performed here. The availability of more
detailed data on oral cavity and pharynx cancers in
AI/AN populations will provide a better estimation of
the burden of cancer, allow a more targeted alloca-
tion of cancer control resources, and facilitate further
examination of trends in incidence as well as analy-
sis of survival, morbidity, and mortality.
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